BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20004578)

  • 1. Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.
    Bridges TM; Kennedy JP; Cho HP; Breininger ML; Gentry PR; Hopkins CR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Jan; 20(2):558-62. PubMed ID: 20004578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators.
    Bridges TM; Kennedy JP; Hopkins CR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5617-22. PubMed ID: 20801651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: development of a potent and highly selective M1 PAM.
    Bridges TM; Phillip Kennedy J; Noetzel MJ; Breininger ML; Gentry PR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1972-5. PubMed ID: 20156687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.
    Bridges TM; Marlo JE; Niswender CM; Jones CK; Jadhav SB; Gentry PR; Plumley HC; Weaver CD; Conn PJ; Lindsley CW
    J Med Chem; 2009 Jun; 52(11):3445-8. PubMed ID: 19438238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor.
    Abdul-Ridha A; Lane JR; Mistry SN; López L; Sexton PM; Scammells PJ; Christopoulos A; Canals M
    J Biol Chem; 2014 Nov; 289(48):33701-11. PubMed ID: 25326383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dronedarone Modulates M1 and M3 Muscarinic Receptors with Subtype Selectivity, Functional Selectivity, and Probe Dependence.
    Jayasuriya GM; Elmslie G; Burstein ES; Ellis J
    Pharmacology; 2017; 99(3-4):128-138. PubMed ID: 27992867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous activation of mGlu
    Cieślik P; Domin H; Chocyk A; Gruca P; Litwa E; Płoska A; Radulska A; Pelikant-Małecka I; Brański P; Kalinowski L; Wierońska JM
    Neuropharmacology; 2020 Sep; 174():107866. PubMed ID: 31785263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic acetylcholine receptor binding affinities of pethidine analogs.
    Lee NR; Zhang X; Darna M; Dwoskin LP; Zheng G
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5032-5. PubMed ID: 26494260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the binding site of novel selective positive allosteric modulators at the M
    Khajehali E; Valant C; Jörg M; Tobin AB; Conn PJ; Lindsley CW; Sexton PM; Scammells PJ; Christopoulos A
    Biochem Pharmacol; 2018 Aug; 154():243-254. PubMed ID: 29777683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators.
    Berizzi AE; Gentry PR; Rueda P; Den Hoedt S; Sexton PM; Langmead CJ; Christopoulos A
    Mol Pharmacol; 2016 Oct; 90(4):427-36. PubMed ID: 27461343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M1 receptors mediate cholinergic modulation of excitability in neocortical pyramidal neurons.
    Gulledge AT; Bucci DJ; Zhang SS; Matsui M; Yeh HH
    J Neurosci; 2009 Aug; 29(31):9888-902. PubMed ID: 19657040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).
    Gentry PR; Kokubo M; Bridges TM; Kett NR; Harp JM; Cho HP; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW
    J Med Chem; 2013 Nov; 56(22):9351-5. PubMed ID: 24164599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
    Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further exploration of M₁ allosteric agonists: subtle structural changes abolish M₁ allosteric agonism and result in pan-mAChR orthosteric antagonism.
    Sheffler DJ; Sevel C; Le U; Lovell KM; Tarr JC; Carrington SJ; Cho HP; Digby GJ; Niswender CM; Conn PJ; Hopkins CR; Wood MR; Lindsley CW
    Bioorg Med Chem Lett; 2013 Jan; 23(1):223-7. PubMed ID: 23200253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel allosteric effects of amiodarone at the muscarinic M5 receptor.
    Stahl E; Ellis J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):214-22. PubMed ID: 20348203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and structure-activity relationships study of positive allosteric modulators of the M
    Tanaka H; Negoro K; Koike T; Tsukamoto I; Yokoyama K; Maeda J; Inagaki Y; Shimoshige Y; Ino K; Ishizu K; Takahashi T
    Bioorg Med Chem; 2020 Jul; 28(13):115531. PubMed ID: 32386953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Agonist Shift Assay Development for the Analysis of M
    Homsher MF; Beshore DC; Cassaday J; Squadroni B; Mohammed E; Hartnett M; Day S; Ma L; Pechter D; Smith MD; Monsma F; Zuck P; Finley MF; Uebele VN; Hermes JD
    SLAS Discov; 2017 Sep; 22(8):1060-1066. PubMed ID: 28426939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): the development of ML169, an MLPCN probe.
    Reid PR; Bridges TM; Sheffler DJ; Cho HP; Lewis LM; Days E; Daniels JS; Jones CK; Niswender CM; Weaver CD; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2011 May; 21(9):2697-701. PubMed ID: 21194936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor.
    Mistry SN; Lim H; Jörg M; Capuano B; Christopoulos A; Lane JR; Scammells PJ
    ACS Chem Neurosci; 2016 May; 7(5):647-61. PubMed ID: 26891194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.
    Ma L; Seager MA; Wittmann M; Jacobson M; Bickel D; Burno M; Jones K; Graufelds VK; Xu G; Pearson M; McCampbell A; Gaspar R; Shughrue P; Danziger A; Regan C; Flick R; Pascarella D; Garson S; Doran S; Kreatsoulas C; Veng L; Lindsley CW; Shipe W; Kuduk S; Sur C; Kinney G; Seabrook GR; Ray WJ
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15950-5. PubMed ID: 19717450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.